WHO approves Bavarian Nordic’s mpox vaccine for adolescents
World Health Organisation (WHO) on Monday approved Bavarian Nordic’s (BAVA.CO) new tab mpox vaccine for adolescents aged 12 to 17 years. It said the age group is considered especially vulnerable to outbreaks of the disease that has triggered global concern.…